About American Shared Hospital Services
- Industry: Health Care
- Exchange: NYSE MKT LLC
- Country: US
- Website: https://ashs.com/
Frequently Asked Questions
What is the 52-week range for AMS?
The 52-week high is $2.81 and the 52-week low is $1.25.
What is the P/E ratio for AMS?
The P/E ratio data is currently unavailable.
What is the dividend yield for AMS?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -7.45%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -5.83%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 0.57.
Analyst Recommendation Trends
Wall Street analyst consensus for AMS over the last few months:
Latest AMS News
What Is Behind ams-OSRAM (SWX:AMS) Stock Dropping Today?
ams-OSRAM (SWX:AMS) has put advanced photonics for AI infrastructure in focus, unveiling new micro-emitter and photodiode arrays, thin-film VCSEL technology, and a BizLink-backed multi-core fiber demonstrator at ECOC 2026 in Malaga. Against this product backdrop, ams-OSRAM’s 1-month share price return of 18.14% and 90-day gain of 16.54% point to building momentum, even after a recent 7-day share price pullback of 8.18% and a one-day dip of 2.18% to CHF21.56. Scan how ams-OSRAM compares with...
ams OSRAM (SWX:AMS) Stock Looks Undervalued On Its 150% Run
ams-OSRAM has delivered a very strong share price gain year to date, and that kind of move naturally raises a basic question for investors who care about valuation. Does the current market value line up with what the company is generating in sales, or has the share price moved ahead of the underlying business activity? The stock is up 150.3% year to date, which puts a lot of weight on the question of whether today's valuation can be grounded in the revenue it is producing. Recent...
Novartis Trial Failure Sparks Biopharma Options Frenzy
3 biopharma stocks seeing high options volume
Form 8.3
LONDON, September 07, 2026-- FORM 8.3
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-07-22 | Stachowiak Raymond C | +220,000 | - | - |
| 2026-06-22 | Stachowiak Raymond C | +586,468 | $2.28 | $1,337,147 |
| 2026-03-26 | Stachowiak Raymond C | +100,000 | - | - |